
|Podcasts|February 11, 2022
Platform Processes for Streamlined Regulatory Filing and Decreased Time to Market for Gene Therapies
Author(s)Catalent
One of the challenges facing gene therapy manufacturing is the lack of standardization in the process. Standardized methods, materials, analytics, and documentation can help reduce supply chain bottlenecks, increase efficiencies and lead to accelerated development timelines and smoother regulatory filings. In this podcast, we will discuss how Catalent is working to simplify the supply chain, develop processes scalable for late-stage and commercial needs, and accelerate timelines for production of clinical materials
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
2
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
5



